Freeline Therapeutics Holdings plc Quarterly Common Stock, Shares Authorized from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Freeline Therapeutics Holdings plc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2019 to Q3 2023.
  • Freeline Therapeutics Holdings plc Common Stock, Shares Authorized for the quarter ending September 30, 2023 was 400M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 400M 0 0% Sep 30, 2023 6-K 2023-12-01
Q2 2023 400M 0 0% Jun 30, 2023 6-K 2023-08-15
Q1 2023 400M +240M +150% Mar 31, 2023 6-K 2023-05-30
Q4 2022 400M +240M +150% Dec 31, 2022 6-K 2023-12-01
Q3 2022 400M +240M +150% Sep 30, 2022 6-K 2022-11-15
Q2 2022 400M +240M +150% Jun 30, 2022 6-K 2022-08-09
Q1 2022 160M 0 0% Mar 31, 2022 6-K 2022-05-10
Q4 2021 160M 0 0% Dec 31, 2021 20-F 2023-04-04
Q3 2021 160M Sep 30, 2021 6-K 2021-11-09
Q2 2021 160M -540M -77.1% Jun 30, 2021 6-K 2021-08-16
Q1 2021 160M Mar 31, 2021 6-K 2021-05-17
Q4 2020 160M -540M -77.1% Dec 31, 2020 20-F 2022-03-31
Q2 2020 700M Jun 30, 2020 6-K 2020-10-29
Q4 2019 700M Dec 31, 2019 6-K 2020-10-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.